Cellectar Biosciences to Present at the LD Micro Invitational Conference
May 30, 2017 12:42 pm UTC| Business
MADISON, Wis., May 30, 2017 -- Cellectar Biosciences (Nasdaq:CLRB), an oncology-focused biotechnology company, today announced that it will be presenting at the 7th annual LD Micro Invitational onTuesday, June 6 at...
Cellectar Biosciences to Present at the LD Micro Invitational Conference
May 30, 2017 12:42 pm UTC| Business
MADISON, Wis., May 30, 2017 -- Cellectar Biosciences (Nasdaq:CLRB), an oncology-focused biotechnology company, today announced that it will be presenting at the 7th annual LD Micro Invitational onTuesday, June 6 at...
Cellectar Biosciences to Present at the LD Micro Invitational Conference
May 30, 2017 12:42 pm UTC| Business
MADISON, Wis., May 30, 2017 -- Cellectar Biosciences (Nasdaq:CLRB), an oncology-focused biotechnology company, today announced that it will be presenting at the 7th annual LD Micro Invitational onTuesday, June 6 at...
Cellectar Biosciences to Present at the LD Micro Invitational Conference
May 30, 2017 12:42 pm UTC| Business
MADISON, Wis., May 30, 2017 -- Cellectar Biosciences (Nasdaq:CLRB), an oncology-focused biotechnology company, today announced that it will be presenting at the 7th annual LD Micro Invitational onTuesday, June 6 at...
May 30, 2017 12:41 pm UTC| Business
CAMBRIDGE, Mass., May 30, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of...
May 30, 2017 12:41 pm UTC| Business
CAMBRIDGE, Mass., May 30, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of...
May 30, 2017 12:41 pm UTC| Business
CAMBRIDGE, Mass., May 30, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of...